NGS technology helps to drive precision medicine in Sweden

The evolution of technologies used to characterize hematological malignancies has driven progress in clinical cancer research. Starting with FISH, PCR and microarrays, rapid technology development has delivered powerful next-generation sequencing (NGS) tools which have the potential to transform clinical diagnostics.

Watch the video to hear Prof. Richard Rosenquist Brandell present the whole genome sequencing work being done at SciLifeLab in Sweden to implement precision medicine at a national level.